23-25 April 2018
Boston, MA, USA

Register by Friday, October 27 to save up to $600

Non- alcoholic steatohepatitis (NASH) is growing in status as ‘the next big global epidemic’. With no FDA approved treatments, NASH drug developers are racing to deliver on this huge unmet medical need.

Focused on overcoming key industry challenges from drug discovery to late stage clinical development, the 2nd Annual NASH Summit is the most comprehensive learning and networking forum dedicated to accelerating your NASH drug development. View 2018 Draft Agenda.

Across 3 packed days, 50+ drug developers will showcase the latest insight, data and lessons learned giving you an unparalleled breadth and depth of content. Learn how to:

  • Identify and validate novel targets for better efficacious drugs
  • Achieve greater translation of preclinical outcomes to accelerate entrance into the clinic
  • Confidently utilize patient subpopulations for better designed, more worthwhile clinical trials

Be part of cross-industry discussions with 200 of your peers across 120 organisations and discover how to fast-track your NASH drug candidate development at this must-attend meeting.

“Well planned, and executed. Top notch organization. Gold standard of focused conferences.”
BioTelemetry Research

“Best meeting for industries and valuable information. This meeting makes my understanding for current situation and future perspectives deeper.”
Shionogi Co & Ltd

Homepage widget
Media Partner